■ PEPTIDE NEWS · LIVE

NEWS.

Peptide research, regulation, discovery. Every story links to the peptide it’s about.

RSS
ALL 363 GLP-1 69 Regulatory 25 Clinical 201 AI / Compute 14 Industry 23 Platform 31
The EMA just put a quality floor under synthetic peptide manufacturing

The EMA's first dedicated guideline for synthetic peptide active substances took legal effect on June 1, setting manufacturing and impurity-control standards for the chemistry behind drugs like Wegovy and Mounjaro. It lands as France becomes the first EU country to reimburse them.

Jun 20, 2026 · Regulatory · @pavel GLP-1RGIPR 3 min read
A GLP-1 drug infused during heart surgery didn't protect the lungs

In an 878-patient substudy of the GLORIOUS trial, a continuous exenatide infusion during cardiopulmonary bypass left three-month lung function no better than placebo. Both groups lost about 7.7 points of diffusing capacity, and the drug groups did not separate.

Jun 20, 2026 · Clinical · @pavel GLP-1R 3 min read
Half the children on teduglutide weaned off IV feeding

In a single-center cohort of 41 children with short bowel syndrome, the GLP-2 peptide teduglutide got 21 (about half) off intravenous nutrition entirely, with a median 7.3 months to wean. Response tracked residual bowel length.

Jun 19, 2026 · Clinical · @pavel GLP-2R 3 min read
Prions are known for misfolding. An AI found antibiotics inside them.

A deep-learning model screened 19.3 million fragments cut from prion proteins and flagged 1,179 antibiotic candidates. Of 75 the Penn team synthesized, 59 killed bacteria and two cleared infections in mice.

Jun 19, 2026 · AI / Compute · @pavel ANTIMICROBIAL 3 min read
Achondroplasia growth drugs added half an inch a year. The disproportion didn't change.

The first pooled analysis of the CNP analogs vosoritide and navepegritide found about 1.36 cm a year of extra growth in children with achondroplasia, but no change in the body-proportion ratio that defines the condition.

Jun 19, 2026 · Clinical · @pavel 3 min read
A peptide reverse-engineered from a death protein protected three organs in animals

German researchers rebuilt the cell-death protein BNIP3 into B-017, an antagonist peptide that kept the mitochondrial self-destruct switched off and reduced damage in the heart, brain, and liver of animals.

Jun 19, 2026 · Platform · @pavel MITOCHONDRIALNEUROPROTECTIVE 3 min read
In IVF, blood oxytocin tracked failure. Follicle oxytocin tracked success.

A prospective study of 320 IVF cycles found the same hormone pointing opposite ways: higher oxytocin in the blood meant lower odds of a live birth, while higher oxytocin in the fluid around the egg meant better odds. The compartment, not the molecule, changed the sign.

Jun 18, 2026 · Clinical · @pavel OXTR 4 min read
One peptide shot grew muscle for 12 weeks. The mechanism stalled in old mice.

A single injection of MID-35, a mirror-image myostatin blocker, enlarged mouse leg muscle for three months. The fat-signal it leaned on to wake muscle stem cells rose in young and adult mice but never showed up in aged ones, the muscle a real drug would target.

Jun 18, 2026 · Platform · @pavel GDF-8GDF-11ACTIVIN-AACTRIIB 4 min read
A peptide vaccine kept most kids with refractory leukemia alive after transplant

In a 17-child phase II study, a WT1 peptide vaccine given as post-transplant maintenance reached 70.6 percent three-year survival, and the children whose killer T cells actually responded survived far better than those whose did not.

Jun 18, 2026 · Clinical · @pavel ANTICANCERIMMUNE 4 min read
Semaglutide was linked to half the seizure risk. Weight loss didn't explain it.

A target trial emulation in All of Us found adults who started semaglutide were about half as likely to develop a new seizure disorder, and the benefit ran through neither glucose control nor weight loss.

Jun 18, 2026 · GLP-1 · @pavel GLP-1R 4 min read
A dengue-virus peptide ferried a radioactive tracer into the brain. Tumor proof is next.

A chimeric peptide stitches a glioblastoma-homing sequence to a 7-amino-acid fragment of the dengue virus, then carries gallium-67 or lutetium-177 across the blood-brain barrier. In cells and healthy mice it works, but brain uptake is low and no tumor has been treated yet.

Jun 17, 2026 · Platform · @pavel ANTICANCER 4 min read
JAMA calls the injectable-peptide boom a regulatory gray zone

A JAMA Viewpoint counts 130,000 Instagram posts and 230 million TikTok views for injectable peptides like BPC-157 and TB-500, and warns the safety research and rules have not caught up. The FDA weighs seven of them for legal compounding on July 23.

Jun 17, 2026 · Regulatory · @pavel TISSUE-REPAIRLONGEVITYNEUROPROTECTIVEMITOCHONDRIAL 3 min read
An engineered pore reads peptides the way nanopores read DNA

A Nature Nanotechnology team used a modified bacterial pore to tell all 20 amino acids apart, read peptides up to 39 residues long, and reconstruct a peptide's sequence from overlapping fragments at up to 97.4 percent accuracy, clearing the obstacle that has kept protein nanopore sequencing stuck for years.

Jun 16, 2026 · Platform · @pavel 4 min read
GLP-1 drugs cut heart events even in people who aren't obese

A meta-analysis of 12 trials and 91,167 patients found GLP-1 receptor agonists reduced major heart events and cardiovascular death by about a fifth in people with a BMI under 30, the same size of benefit seen in obese patients, with no sign the effect depends on starting weight.

Jun 16, 2026 · GLP-1 · @pavel GLP-1R 3 min read
GLP-1 drugs eased a brutal skin disease more than the weight loss explains

A June 15 systematic review in the American Journal of Clinical Dermatology pooled 19 studies and 67,568 patients and linked GLP-1 receptor agonists to real improvement in hidradenitis suppurativa, a painful inflammatory skin disease. Sixty percent of patients dropped at least one Hurley severity stage, quality-of-life scores improved by 3.83 points, and C-reactive protein and HbA1c both fell. The catch that makes it interesting: average BMI fell only 2.64 kg/m2, too little to explain the skin gains on its own, hinting the drugs' anti-inflammatory side is doing real work, though the mostly observational evidence cannot prove it.

Jun 16, 2026 · GLP-1 · @pavel GLP-1RIMMUNE 4 min read
← NEWER PAGE 11 OLDER →